Nonamnestic Alzheimer disease (AD) variants, including posterior cortical atrophy and the logopenic variant of primary progressive aphasia, differ from amnestic AD in distributions of tau aggregates and neurodegeneration. We evaluated whether 18F-flortaucipir (also called 18F-AV-1451) PET, targeting tau aggregates, detects these differences, and we compared the results with MRI measures of gray matter (GM) atrophy. Methods: Five subjects with posterior cortical atrophy, 4 subjects with the logopenic variant of primary progressive aphasia, 6 age-matched patients with AD, and 6 control subjects underwent 18F-flortaucipir PET and MRI. SUV ratios and GM volumes were compared using regional and voxel-based methods. Results: The subgroups showed the expected 18F-flortaucipir-binding patterns. Group effect sizes were generally stronger with 18F-flortaucipir PET than with MRI volumes. There were moderate-to-high correlations between regional GM atrophy and 18F-flortaucipir uptake. 18F-flortaucipir binding and GM atrophy correlated similarly to cognitive test performance. Conclusion: 18F-flortaucipir binding corresponds to the expected neurodegeneration patterns in nonamnestic AD, with potential for earlier detection of pathology than is possible with MRI atrophy measures.
Nonamnestic Alzheimer disease (AD) variants, including posterior cortical atrophy and the logopenic variant of primary progressive aphasia, differ from amnestic AD in distributions of tau aggregates and neurodegeneration. We evaluated whether 18F-flortaucipir (also called 18F-AV-1451) PET, targeting tau aggregates, detects these differences, and we compared the results with MRI measures of gray matter (GM) atrophy. Methods: Five subjects with posterior cortical atrophy, 4 subjects with the logopenic variant of primary progressive aphasia, 6 age-matched patients with AD, and 6 control subjects underwent 18F-flortaucipir PET and MRI. SUV ratios and GM volumes were compared using regional and voxel-based methods. Results: The subgroups showed the expected 18F-flortaucipir-binding patterns. Group effect sizes were generally stronger with 18F-flortaucipir PET than with MRI volumes. There were moderate-to-high correlations between regional GM atrophy and 18F-flortaucipir uptake. 18F-flortaucipir binding and GM atrophy correlated similarly to cognitive test performance. Conclusion:18F-flortaucipir binding corresponds to the expected neurodegeneration patterns in nonamnestic AD, with potential for earlier detection of pathology than is possible with MRI atrophy measures.
Authors: Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps Journal: Alzheimers Dement Date: 2011-04-21 Impact factor: 21.566
Authors: David A Wolk; Julie C Price; Charles Madeira; Judy A Saxton; Beth E Snitz; Oscar L Lopez; Chester A Mathis; William E Klunk; Steven T DeKosky Journal: Alzheimers Dement Date: 2012-01-30 Impact factor: 21.566
Authors: Clifford R Jack; Prashanthi Vemuri; Heather J Wiste; Stephen D Weigand; Paul S Aisen; John Q Trojanowski; Leslie M Shaw; Matthew A Bernstein; Ronald C Petersen; Michael W Weiner; David S Knopman Journal: Arch Neurol Date: 2011-08-08
Authors: Sergey Shcherbinin; Adam J Schwarz; Abhinay Joshi; Michael Navitsky; Matthew Flitter; William R Shankle; Michael D Devous; Mark A Mintun Journal: J Nucl Med Date: 2016-05-05 Impact factor: 10.057
Authors: Julian Dronse; Klaus Fliessbach; Gérard N Bischof; Boris von Reutern; Jennifer Faber; Jochen Hammes; Georg Kuhnert; Bernd Neumaier; Oezguer A Onur; Juraj Kukolja; Thilo van Eimeren; Frank Jessen; Gereon R Fink; Thomas Klockgether; Alexander Drzezga Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472
Authors: Manja Lehmann; Pia M Ghosh; Cindee Madison; Robert Laforce; Chiara Corbetta-Rastelli; Michael W Weiner; Michael D Greicius; William W Seeley; Maria L Gorno-Tempini; Howard J Rosen; Bruce L Miller; William J Jagust; Gil D Rabinovici Journal: Brain Date: 2013-01-28 Impact factor: 13.501
Authors: Maria Luisa Gorno-Tempini; Nina F Dronkers; Katherine P Rankin; Jennifer M Ogar; La Phengrasamy; Howard J Rosen; Julene K Johnson; Michael W Weiner; Bruce L Miller Journal: Ann Neurol Date: 2004-03 Impact factor: 10.422
Authors: Jennifer L Whitwell; Peter Martin; Jonathan Graff-Radford; Mary M Machulda; Matthew L Senjem; Christopher G Schwarz; Stephen D Weigand; Anthony J Spychalla; Daniel A Drubach; Clifford R Jack; Val J Lowe; Keith A Josephs Journal: Alzheimers Dement Date: 2019-03-08 Impact factor: 21.566
Authors: Irene Sintini; Christopher G Schwarz; Peter R Martin; Jonathan Graff-Radford; Mary M Machulda; Matthew L Senjem; Robert I Reid; Anthony J Spychalla; Daniel A Drubach; Val J Lowe; Clifford R Jack; Keith A Josephs; Jennifer L Whitwell Journal: Hum Brain Mapp Date: 2018-12-13 Impact factor: 5.038
Authors: Keith A Josephs; Peter R Martin; Hugo Botha; Christopher G Schwarz; Joseph R Duffy; Heather M Clark; Mary M Machulda; Jonathan Graff-Radford; Stephen D Weigand; Matthew L Senjem; Rene L Utianski; Daniel A Drubach; Bradley F Boeve; David T Jones; David S Knopman; Ronald C Petersen; Clifford R Jack; Val J Lowe; Jennifer L Whitwell Journal: Ann Neurol Date: 2018-03-13 Impact factor: 10.422
Authors: Jennifer L Whitwell; Jonathan Graff-Radford; Nirubol Tosakulwong; Stephen D Weigand; Mary M Machulda; Matthew L Senjem; Anthony J Spychalla; Prashanthi Vemuri; David T Jones; Daniel A Drubach; David S Knopman; Bradley F Boeve; Nilüfer Ertekin-Taner; Ronald C Petersen; Val J Lowe; Clifford R Jack; Keith A Josephs Journal: Alzheimers Dement Date: 2018-03-30 Impact factor: 21.566
Authors: Katerina A Tetzloff; Jonathan Graff-Radford; Peter R Martin; Nirubol Tosakulwong; Mary M Machulda; Joseph R Duffy; Heather M Clark; Matthew L Senjem; Christopher G Schwarz; Anthony J Spychalla; Daniel A Drubach; Clifford R Jack; Val J Lowe; Keith A Josephs; Jennifer L Whitwell Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Renaud La Joie; Adrienne V Visani; Suzanne L Baker; Jesse A Brown; Viktoriya Bourakova; Jungho Cha; Kiran Chaudhary; Lauren Edwards; Leonardo Iaccarino; Mustafa Janabi; Orit H Lesman-Segev; Zachary A Miller; David C Perry; James P O'Neil; Julie Pham; Julio C Rojas; Howard J Rosen; William W Seeley; Richard M Tsai; Bruce L Miller; William J Jagust; Gil D Rabinovici Journal: Sci Transl Med Date: 2020-01-01 Impact factor: 17.956